Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, September 18, 2023
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
Edward White Reiterated (TGTX) at Strong Buy and Held Target at $41 on, Sep 18th, 2023
Edward White of HC Wainwright & Co., Reiterated "TG Therapeutics, Inc." (TGTX) at Strong Buy and Held Target at $41 on, Sep 18th, 2023.
Edward has made no other calls on TGTX in the last 4 months.
There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Corinne Jenkins of "Goldman Sachs" Maintained at Hold with Decreased Target to $12 on, Thursday, August 3rd, 2023
These are the ratings of the 2 analyists that currently disagree with Edward
- Eric Joseph of "JP Morgan" Maintained at Buy with Decreased Target to $22 on, Monday, August 7th, 2023
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $32 on, Wednesday, August 2nd, 2023
